The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 10,097 | 664,681 | SH | DFND | 1,2 | 664,681 | 0 | 0 | |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 44,504 | 2,752,256 | SH | DFND | 1,2 | 2,752,256 | 0 | 0 | |
ACCELERON PHARMA INC | COM | 00434H108 | 45,143 | 1,036,575 | SH | DFND | 1,2 | 1,036,575 | 0 | 0 | |
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 2,931 | 40,197 | SH | DFND | 1,2 | 40,197 | 0 | 0 | |
ARGENX SE | SPONSORED ADR | 04016X101 | 1,777 | 18,500 | SH | DFND | 1,2 | 18,500 | 0 | 0 | |
ARRAY BIOPHARMA INC | COM | 04269X105 | 26,363 | 1,850,000 | SH | DFND | 1,2 | 1,850,000 | 0 | 0 | |
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 61,512 | 7,622,256 | SH | DFND | 1,2 | 7,622,256 | 0 | 0 | |
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 11,164 | 1,418,489 | SH | DFND | 1,2 | 1,418,489 | 0 | 0 | |
CYTOKINETICS INC | COM | 23282W605 | 20,055 | 3,173,288 | SH | DFND | 1,2 | 3,173,288 | 0 | 0 | |
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 10,163 | 143,481 | SH | DFND | 1,2 | 143,481 | 0 | 0 | |
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 22,305 | 2,398,409 | SH | DFND | 1,2 | 2,398,409 | 0 | 0 | |
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 48,439 | 1,180,000 | SH | DFND | 1,2 | 1,180,000 | 0 | 0 | |
INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 20,158 | 200,000 | SH | Put | DFND | 1,2 | 200,000 | 0 | 0 |
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 2,278 | 200,000 | SH | Put | DFND | 1,2 | 200,000 | 0 | 0 |
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 2,278 | 200,000 | SH | Put | DFND | 1,2 | 200,000 | 0 | 0 |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 49,271 | 5,567,348 | SH | DFND | 1,2 | 5,567,348 | 0 | 0 | |
KRYSTAL BIOTECH INC | COM | 501147102 | 10,226 | 492,100 | SH | DFND | 1,2 | 492,100 | 0 | 0 | |
KURA ONCOLOGY INC | COM | 50127T109 | 38,884 | 2,769,527 | SH | DFND | 1,2 | 2,769,527 | 0 | 0 | |
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 3,100 | 27,500 | SH | DFND | 1,2 | 27,500 | 0 | 0 | |
MENLO THERAPEUTICS INC | COM | 586858102 | 9,082 | 2,204,407 | SH | DFND | 1,2 | 2,204,407 | 0 | 0 | |
MILLENDO THERAPEUTICS INC | COM | 60040X103 | 10,240 | 1,288,093 | SH | DFND | 1,2 | 1,288,093 | 0 | 0 | |
NOVAVAX INC | COM | 670002104 | 4,600 | 2,500,000 | SH | Call | DFND | 1,2 | 2,500,000 | 0 | 0 |
NOVAVAX INC | COM | 670002104 | 3,680 | 2,000,000 | SH | Call | DFND | 1,2 | 2,000,000 | 0 | 0 |
PTC THERAPEUTICS INC | COM | 69366J200 | 42,042 | 1,225,000 | SH | DFND | 1,2 | 1,225,000 | 0 | 0 | |
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 6,431 | 955,618 | SH | DFND | 1,2 | 955,618 | 0 | 0 | |
PROTEOSTASIS THERAPEUTICS INC | COM | 74373B109 | 9,867 | 3,045,423 | SH | DFND | 1,2 | 3,045,423 | 0 | 0 | |
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 28,077 | 1,379,700 | SH | DFND | 1,2 | 1,379,700 | 0 | 0 | |
SAGE THERAPEUTICS INC | COM | 78667J108 | 2,491 | 26,000 | SH | Put | DFND | 1,2 | 26,000 | 0 | 0 |
SAGE THERAPEUTICS INC | COM | 78667J108 | 2,491 | 26,000 | SH | Call | DFND | 1,2 | 26,000 | 0 | 0 |
SAVARA INC CMN | COM | 805111101 | 13,771 | 1,819,195 | SH | DFND | 1,2 | 1,819,195 | 0 | 0 | |
SPARK THERAPEUTICS INC | COM | 84652J103 | 24,682 | 630,600 | SH | DFND | 1,2 | 630,600 | 0 | 0 | |
STREAMLINE HEALTH SOLUTIONS | COM | 86323X106 | 105 | 130,137 | SH | DFND | 1,2 | 130,137 | 0 | 0 | |
SUNESIS PHARMACEUTICALS INC | COM | 867328700 | 132 | 317,962 | SH | DFND | 1,2 | 317,962 | 0 | 0 | |
TG THERAPEUTICS INC | COM | 88322Q108 | 12,300 | 3,000,000 | SH | DFND | 1,2 | 3,000,000 | 0 | 0 | |
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 38,202 | 350,800 | SH | DFND | 1,2 | 350,800 | 0 | 0 | |
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 33,142 | 200,000 | SH | Put | DFND | 1,2 | 200,000 | 0 | 0 |
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 3,432 | 365,132 | SH | DFND | 1,2 | 365,132 | 0 | 0 | |
ZAFGEN INC | COM | 98885E103 | 17,812 | 3,598,392 | SH | DFND | 1,2 | 3,598,392 | 0 | 0 | |
ZOGENIX INC | COM | 98978L204 | 36,460 | 1,000,000 | SH | DFND | 1,2 | 1,000,000 | 0 | 0 | |
OSMOTICA PHARMACEUTICALS PLC | SHS | G6S41R101 | 11,625 | 1,500,000 | SH | DFND | 1,2 | 1,500,000 | 0 | 0 | |
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 14,531 | 4,047,561 | SH | DFND | 1,2 | 4,047,561 | 0 | 0 | |
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 35,346 | 1,657,873 | SH | DFND | 1,2 | 1,657,873 | 0 | 0 |